Injection Devices for Biological Drugs

Tuesday, October 9, 2018 Drug News
Email Print This Page Comment bookmark
Font : A-A+

NEW YORK, Oct. 8, 2018 /PRNewswire/ -- Biological drugs as a class continue to outpace all other NCEs in development pipelines

and clinical trials. Because biological drugs most often target chronic conditions, dosing strategies and treatment protocols must be developed for long-term use, often for self-administration by patients who may have limitations directly related to
their condition. The powerful physiological effects of antibodies, hormones, enzymes and other biological drugs also increase the need for safety and adherence. Cooperation between device designers and drug developers is occurring much earlier in the drug development cycle, allowing device designs in many cases to be tailored to the bioavailability targets and pharmacokinetic profiles of specific drug therapies. New injectable delivery device designs currently being developed will create new opportunities for alternative injection methods. Partnerships between device suppliers and pharmaceutical companies will foster market acceptance of new injection devices for a host of new therapies such as therapeutic vaccines, DNA-based drugs, and protein-derived biologics.Read the full report: https://www.reportlinker.com/p05583804 What You Will Learn What are the product and user requirements that drive the biological drug-device selection process? What are the essential design factors, technologies and market development issues for injection devices capable of administering biological dugs? What is the impact of development-stage biological manufacturing process changes on device go-to-market readiness and how has it changed in recent years? How do device selection decisions align across biological drug classes? Therapeutic targets? Market segments? What is the impact of drug-device dependencies on pre- and post-marketing product life cycle management? What are the significant economic, technology, and regulatory factors affecting the market for biological drug injection devices?Read the full report: https://www.reportlinker.com/p05583804 About Reportlinker ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place. __________________________ Contact Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001

Cision View original content:http://www.prnewswire.com/news-releases/injection-devices-for-biological-drugs-300727027.html

SOURCE Reportlinker



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store